Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 28 Lung Neoplasms 27 Neoplasm Metastasis 26 Carcinoma, Non-Small-Cell Lung 21 Multiple Myeloma 18 Urinary Bladder Neoplasms 16 Breast Neoplasms 16 Lymphoma 15 Glioma 14 Colorectal Neoplasms 14 Pancreatic Neoplasms 13 Lymphoma, Large B-Cell, Diffuse 13 Carcinoma, Renal Cell 13 Squamous Cell Carcinoma of Head and Neck 12 Ovarian Neoplasms 12 Melanoma 12 Triple Negative Breast Neoplasms 11 Glioblastoma 10 Oropharyngeal Neoplasms 9 Mouth Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma 9 Sarcoma 8 Lymphoma, Non-Hodgkin 8 Endometrial Neoplasms 8 Carcinoma, Transitional Cell 8 Medulloblastoma 7 Lymphoma, Follicular 7 Laryngeal Neoplasms 7 Carcinoma, Hepatocellular 7

Interventions

Tamoxifen 4 Specimen Handling 4 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Radiotherapy 1 Radiation 1 Omacor 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Laser Therapy 1 Biopsy 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Magnetic Resonance Spectroscopy × 30 days × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡